Bellevue Group AG boosted its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,091,000 shares of the company’s stock after purchasing an additional 369,500 shares during the period. Revolution Medicines […]
Bain Capital Life Sciences Investors LLC bought a new stake in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 1,112,396 shares of the company’s stock, valued at approximately $31,904,000. Revolution Medicines comprises 3.1% of Bain Capital Life […]
Bain Capital Life Sciences Investors LLC bought a new stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The firm bought 1,112,396 shares of the company’s stock, valued at approximately $31,904,000. Revolution Medicines accounts for 3.1% of Bain Capital Life […]
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) reached a new 52-week high during trading on Wednesday . The company traded as high as $40.63 and last traded at $40.05, with a volume of 295845 shares trading hands. The stock had previously closed at $39.66. Analyst Upgrades and Downgrades Several research analysts have issued reports […]